Month: July 2017
-
Stem Cell Clinics Found Marketing in ClinicalTrials.gov
A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services.
-
Patent Awarded for Exosome Capture Process
A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses.
-
Start-Up Offering Precise Heart Rhythm Diagnostic
A one year-old company in New York City is developing a device that assesses the severity of heart rhythm problems to prescribe a more precise course of treatment.
-
Biotech Licensing Viral T-Cell Immunotherapies
A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine.
-
Plant-Based Diet Quality Key to Reducing Heart Disease
A review of health surveys going back to the 1980s reveals individuals consuming healthier plant-based diets are less likely to encounter heart disease than people eating less-healthy foods from plants or animals.
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
Arizona Medical Marijuana Operators Merge to Create Super Dispensary
Two of the biggest medical marijuana operators in Arizona – Modern Flower and Harvest – have merged to create a super dispensary.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
America’s Overdose Epidemic In Perspective
This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.